Abstract
The molecular mechanism of triple-negative breast cancer(TNBC) remains unclear, and there has been no effective targeted therapy for it. A better understanding of the mechanisms of TNBC is urgently needed to identify new therapeutic targets. In this study, eight cases of premenopausal TNBC patients were collected, and a comparative proteomic analysis of their breast cancer tissues and matched paraneoplastic ones was performed via isobaric tags for relative and absolute quantitation(iTRAQ) technology coupled with two-dimensional liquid chromatography-tandem mass spectrumetry(2D LC-MS/MS). The researches result in the identification of 1254 nonredundant proteins, of which 1243 proteins reached the strict quantitative standard. The quantitative comparison reveal that among the 214 proteins, 81 proteins significantly increased and 133 proteins decreased in TNBC tissues compared to corresponding ones in control. The Gene Ontology(GO) annotations and pathway analysis show their distributions in GO and the marked functions, as well as the closely related signal transduction pathways involved in extra cellular matrix (ECM)-receptor interaction, protein digestion and absorption, renin-angiotensin system, complement and coagulation cascades and focal adhesion. This pilot study will lay a foundation for further searching for therapeutic targets of TNBC and exploring the molecular mechanism, which can also be extended as a part of a large scale biomarker discovery plan.
Similar content being viewed by others
References
Zhao J., Liu Y. Q., Xu Y. Z., Zhang Y. F., Wu J. G., Hou K. Y., Zhao H. M., Lei Y. T., Zhou X. S., Xu Z., Ling X. F., Chem. J. Chinese Universities, 2011, 32(2), 246
Perou C. M., Sørlie T., Eisen M. B., van de Rijn M., Jeffrey S. S., Rees C. A., Pollack J. R., Ross D. T., Johnsen H., Akslen L. A., Fluge O., Pergamenschikov A., Williams C., Zhu S. X., Lønning P. E., Børresen-Dale A. L., Brown P. O., Botstein D., Nature, 2000, 406(6797), 747
Sorlie T., Tibshirani R., Parker J., Hastie T., Marron J. S., Nobel A., Deng S., Johnsen H., Pesich R., Geisler S., Demeter J., Perou C. M., Lønning P. E., Brown P. O., Børresen-Dale A. L., Botstein D., J. Proc Natl. Acad. Sci., 2003, 100(14), 8418
Peddi P. F., Ellis M. J., Ma C., Int. J. Breast Cancer, 2012, 10, 1155
Hudis C.A., Gianni L., J. Oncologist, 2011, 16(Suppl. 1), 1
Benueei F., Int. J. Cancer, 2008, 123(1), 236
Rakha E. A., Elsheikh S. E., Aleskandarany M. A., Habashi H. O., Green A. R., Powe D. G., El-Sayed M. E., Benhasouna A., Brunet J. S., Akslen L. A., Evans A. J., Blamey R., Reis-Filho J. S., Foulkes W. D., Ellis I. O., Clinical Cancer Research, 2009, 15(7), 2302
Dent R., Trudeau M., Pritchard K. I., Hanna W. M., Kahn H. K., Sawka C. A., Lickley L. A., Rawlinson E., Sun P., Narod S. A., Clin. Cancer Res., 2007, 13, 4429
Ross P. L., Huang Y. N., Marchese J. N., Williamson B., Parker K., Hattan S., Khainovski N., Pillai S., Dey S., Daniels S., Purkayastha S., Juhasz P., Martin S., Bartlet-Jones M., He F., Jacobson A., Pappin D. J., Mol. Cell Proteomics, 2004, 3(12), 1154
Lu W. D., Qiu J., Zhao G. X., Qie L. Y., Wei X. B., Gao H. Q., Chem. Res. Chinese Universities, 2012, 28(6), 1035
Sutton C. W., Rustogi N., Gurkan C., Scally A., Loizidou M. A., Hadjisavvas A., Kyriacou K., J. Proteome Res., 2010, 9(8), 3891
Bouchal P., Roumeliotis T., Hrstka R., Nenutil R., Vojtesek B., Garbis S.D., J. Proteome Res., 2009, 8(1), 362
Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., Katayama T., Kawashima S., Okuda S., Tokimatsu T., Yamanishi Y., Nucleic Acids Res., 2008, 36, 480
Weinstat-Saslow D. L., Zabrenetzky V. S., van Houtte K., Frazier W. A., Roberts D. D., Steeg P. S., Cancer Res., 1994, 54, 6504
Chandrasekaran S., Guo N. H., Rodrigues R. G., Kaiser J., Roberts D. D., J. Biol. Chem., 1999, 274(16), 11408
Hsu S., Qin H., Dickinson D., Xie D., Bollag W. B., Stoppler H., Pearl H., Vu A., Watkins M., In vivo, 2007, 21(2), 279
Fang H. Y., Chen C. Y., Hung M. F., Hsiao Y. T., Chiang T. C., Lin T. Y., Chang H. W., Chow K. C., Ko W. J., Oncol. Rep., 2011, 26(2), 359
Oxford G., Owens C. R., Titus B. J., Foreman T. L., Herlevsen M. C., Smith S. C., Theodorescu D., Cancer Res., 2005, 65(16), 7111
Cancemi P., di Cara G., Albanese N. N., Costantini F., Marabeti M. R., Musso R., Lupo C., Roz E., Pucci-Minafra I., BMC Cancer, 2010, 10, 476
Lehmann B. D., Bauer J. A., Chen X., Sanders M. E., Chakravarthy A. B., Shyr Y., Pietenpol J. A., J. Clin. Invest., 2011, 121(7), 2750
Krupp M., Maass T., Marquardt J. U., Staib F., Bauer T., König R., Biesterfeld S., Galle P. R., Tresch A., Teufel A., BMC Medical Genomics, 2011, 4, 53
Wei Z., Li H., Bioinformatics, 2007, 23(12), 1537
Namazi S., Monabati A., Ardeshir-Rouhani-Fard S., Azarpira N., Mol. Carcinog., 2010, 49(12), 1022
Du N., Feng J., Hu L. J., Sun X., Sun H., Zhao Y., Yang Y. P., Ren H., Oncol. Rep., 2012, 27(6), 1893
Ramírez-Expósito M. J., Carrera-González M. P., Mayas M. D., Dueñas B., Martínez-Ferrol J., Martínez-Martos J. M., Maturitas, 2012, 72(1), 79
Xi B., Zeng T., Liu L., Liang Y., Liu W., Hu Y., Li J., Breast Cancer Res. Treat., 2011, 130(2), 561
Vinson G. P., Barker S., Puddefoot J. R., Endocr. Relat. Cancer, 2012, 19(1), R1
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China(No.81041098).
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Liang, Jl., Li, Sj., Liu, Xg. et al. Quantitative proteomic studies on TNBC in premenopausal patients. Chem. Res. Chin. Univ. 29, 500–505 (2013). https://doi.org/10.1007/s40242-013-2497-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-013-2497-9